In addition, average V/J pairing usage analysis for these particular shared clones reveals more oligoclonal CD8+ T cells expansion for certain TCRB V/J combinations in the tumor after treatment with Bisp-AFN compared with control (Fig. 10J-K). The gene discussed is CD8A; the disease is neoplasm.